Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Danny M Cohn"'
Autor:
Remy S. Petersen, MD, Lauré M. Fijen, MD, PhD, Laurens E. Franssen, MD, PhD, Josephine M.I. Vos, MD, PhD, Danny M. Cohn, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100322- (2024)
Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.
Externí odkaz:
https://doaj.org/article/6c20e97b8c52416c88335adfdabeabe4
Autor:
Danny M. Cohn, Emel Aygören‐Pürsün, Jonathan A. Bernstein, Henriette Farkas, William R. Lumry, Marcus Maurer, Andrea Zanichelli, Matthew Iverson, James Hao, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Marc A. Riedl
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Background Hereditary angioedema (HAE) with C1‐inhibitor deficiency (HAE‐C1‐INH) is characterized by recurrent, debilitating episodes of swelling. Sebetralstat, an investigational oral plasma kallikrein inhibitor, demonstrated promisin
Externí odkaz:
https://doaj.org/article/fa5357d5066e444bb5ad301768e9507f
Autor:
Julia Eder, Marta Bermejo-Jambrina, Killian E. Vlaming, Tanja M. Kaptein, Viktoria Zaderer, E. Marleen Kemper, Doris Wilflingseder, Sietze Reitsma, Godelieve J. de Bree, Danny M. Cohn, Teunis B. H. Geijtenbeek
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT New SARS-CoV-2 variants of concern and waning immunity demonstrate the need for a quick and simple prophylactic agent to prevent infection. Low molecular weight heparins (LMWH) are potent inhibitors of SARS-CoV-2 binding and infection in vit
Externí odkaz:
https://doaj.org/article/be136ae2d1a34d2388548dd0bfd91721
Autor:
Marcus Maurer, MD, Markus Magerl, MD, Stephen Betschel, MD, Werner Aberer, MD, Ignacio J. Ansotegui, MD, PhD, Emel Aygören-Pürsün, MD, Aleena Banerji, MD, Noémi-Anna Bara, MD, Isabelle Boccon-Gibod, MD, Konrad Bork, MD, Laurence Bouillet, Pr, MD, PhD, Henrik Balle Boysen, Nicholas Brodszki, MD, PhD, Paula J. Busse, MD, Anette Bygum, MD, DMSci, Teresa Caballero, MD, PhD, Mauro Cancian, MD, PhD, Anthony J. Castaldo, Danny M. Cohn, MD, PhD, Dorottya Csuka, MD, Henriette Farkas, MD, PhD, DSc, Mark Gompels, MBBS, BSc, MD, Richard Gower, MD, Anete S. Grumach, MD, PhD, Guillermo Guidos-Fogelbach, MD, PhD, Michihiro Hide, MD, PhD, Hye-Ryun Kang, MD, PhD, Allen P. Kaplan, MD, Constance H. Katelaris, MBBS, PhD, Sorena Kiani-Alikhan, PhD, Wei-Te Lei, MD, Richard F. Lockey, MD, Hilary Longhurst, PhD, William Lumry, MD, Andrew MacGinnitie, MD, PhD, Alejandro Malbran, MD, PhD, Inmaculada Martinez Saguer, MD, Juan José Matta Campos, MD, Alexander Nast, MD, Dinh Nguyen, MD, PhD, Sandra A. Nieto-Martinez, MD, Ruby Pawankar, MD, PhD, Jonathan Peter, MB ChB, MMed, FCP (SA), PhD, Grzegorz Porebski, MD, Nieves Prior, MD, PhD, Avner Reshef, MD, Marc Riedl, MD, Bruce Ritchie, MD, Farrukh Rafique Sheikh, MBBS, William B. Smith, MBBS, PhD, Peter J. Spaeth, PhD, Marcin Stobiecki, MD, Elias Toubi, MD, Lilian Agnes Varga, PhD, Karsten Weller, MD, Andrea Zanichelli, MD, Yuxiang Zhi, MD, Bruce Zuraw, MD, Timothy Craig, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 3, Pp 100627- (2022)
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance f
Externí odkaz:
https://doaj.org/article/8b9e359b6d224c3ca799a778ade61235
Autor:
Lauré M. Fijen, Remy S. Petersen, Joost C. M. Meijers, Laura Bordone, Marcel Levi, Danny M. Cohn
Publikováno v:
Thrombosis and haemostasis, 122(12), 2045-2049. Schattauer GmbH
Background Congenital prekallikrein deficiency has been associated with increased risk of thrombosis in a few uncontrolled studies. Prekallikrein levels were reduced by 36-94% (median 75%) in a phase 2 study with the prekallikrein specific antisense
Autor:
Arjen J. Cupido, Remy S. Petersen, Amand F. Schmidt, Marcel Levi, Danny M. Cohn, Lauré M. Fijen
Publikováno v:
Journal of Thrombosis and Haemostasis.
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice.
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice. Elsevier Inc.
Journal of Allergy and Clinical Immunology: In Practice
Journal of Allergy and Clinical Immunology: In Practice
Background: According to the current treatment guidelines, the goals of treatment of patients with hereditary angioedema (HAE) are to achieve total control of the disease and to normalize patients’ lives. Objective: This study aims to establish the
Autor:
Emel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, Mauro Cancian, Roman Hakl, Tamar Kinaciyan, Markus Magerl, Inmaculada Martinez-Saguer, Marcin Stobiecki, Henriette Farkas, Sorena Kiani-Alikhan, Vesna Grivcheva-Panovska, Jonathan A Bernstein, H Henry Li, Hilary J Longhurst, Paul K Audhya, Michael D Smith, Christopher M Yea, Andreas Maetzel, Daniel K Lee, Edward P Feener, Richard Gower, William R Lumry, Aleena Banerji, Marc A Riedl, Marcus Maurer
Publikováno v:
The Lancet, 401(10375), 458-469. Elsevier Limited
Background: Guidelines recommend effective on-demand therapy for all individuals with hereditary angioedema. We aimed to assess the novel oral plasma kallikrein inhibitor, sebetralstat, which is in development, for on-demand treatment of hereditary a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd222b086018bb478d12029297cd21f
https://ruj.uj.edu.pl/xmlui/handle/item/309592
https://ruj.uj.edu.pl/xmlui/handle/item/309592
Publikováno v:
Seminars in thrombosis and hemostasis. Thieme Medical Publishers
Hereditary angioedema is a rare, genetic disorder characterized by painful, debilitating and potentially life-threatening angioedema attacks in subcutaneous and submucosal tissue. While usually unpredictable, attacks can be provoked by a variety of t